ChristineNicholsKayMD
Ophthalmology • Gainesville, FLRetinal Disease
Assistant Professor, Ophthalmology, University of Florida College of Medicine
Are you Dr. Kay?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 58 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
4340 Newberry Rd
Ste 202
Gainesville, FL 32607Phone+1 352-371-2800Fax+1 352-378-7009
Summary
- Dr. Christine Kay, MD is a board certified ophthalmologist in Gainesville, Florida. She is currently licensed to practice medicine in Florida and Iowa. She is affiliated with North Florida/South Georgia Veteran's Health System and is an Assistant Professor at University of Florida College of Medicine.
Education & Training
University of South Florida MorsaniResidency, Ophthalmology, 2006 - 2009
Carilion Clinic-Virginia Tech Carilion School of MedicineInternship, Transitional Year, 2005 - 2006
University of Florida College of MedicineClass of 2005
University of Iowa Hospitals and ClinicsResidency, Ophthalmology
Certifications & Licensure
FL State Medical License 2007 - 2026
IA State Medical License 2009 - 2011- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Clinical and Genetic Characterization of Individuals With Achromatopsia Start of enrollment: 2013 Jun 01
- Vascular Reparative Mechanism in Diabetes Start of enrollment: 2011 Oct 30
- Safety and Efficacy Trial of AAV Gene Therapy in Patients With CNGA3 Achromatopsia (A Clarity Clinical Trial) Start of enrollment: 2017 Aug 03
- Join now to see all
Publications & Presentations
PubMed
- 364 citationsCurrent Clinical Applications of In Vivo Gene Therapy with AAVs.Jerry R. Mendell, Samiah Al-Zaidy, Louise R. Rodino-Klapac, Kimberly Goodspeed, Steven J. Gray
Molecular Therapy. 2021-02-03 - 8 citationsPhotoreceptor recovery following laser photocoagulation and albendazole in diffuse unilateral subacute neuroretinitis.Ryan M. Tarantola, Kori A Elkins, Christine N. Kay, James C. Folk
Archives of Ophthalmology. 2011-05-09 - 76 citationsAssessing Photoreceptor Structure in Retinitis Pigmentosa and Usher Syndrome.Lynn W. Sun, Ryan D. Johnson, Christopher S Langlo, Robert F. Cooper, Moataz M Razeen
Investigative Ophthalmology & Visual Science. 2016-05-01
Authored Content
- Retinal Gene Therapies in Clinical TrialsMarch 2019
Press Mentions
Alkeus Secures Rare Pediatric Disease and Fast Track FDA Designations for Gildeuretinol in Stargardt DiseaseNovember 19th, 2024- Atsena Therapeutics Announces Positive 6-Month Data from Ongoing Phase I/II Clinical Trial of ATSN-101 in Patients with Leber Congenital Amaurosis Caused by Biallelic Mutations in GUCY2D (LCA1)April 25th, 2023
- Atsena Therapeutics Announces Positive Results from Phase I/II Clinical Trial of ATSN-101 for the Treatment of GUCY2D-Associated Leber Congenital Amaurosis (LCA1)October 3rd, 2022
- Join now to see all
